Combined Flow Cytometry and Morphology Review
Use
The Combined Flow Cytometry and Morphology Review is used for the immunophenotyping of myeloid and lymphoid markers alongside an H&E morphology review. This test aids in the diagnosis and classification of leukemia and lymphoma by providing detailed information on the cellular makeup and associated markers.
Special Instructions
This test is intended for clinical trials or research purposes only and is not validated for regular clinical use. It requires appropriate handling and storage conditions, including shipping under refrigerated conditions to maintain specimen stability.
Limitations
The test results may be affected by specimen condition, including improper storage temperatures or use of inappropriate anticoagulants. Hemolyzed or clotted specimens, non-viable specimens, or those with insufficient cell count may lead to rejection of the sample. Thus, careful adherence to specimen collection and submission guidelines is imperative.
Methodology
Cell-based / Cytometry (Flow Cytometry)
Biomarkers
Result Turnaround Time
5 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
4 mL
Minimum Volume
0.5 mL with 107 cells
Container
NaHep preferred (EDTA accepted)
Causes for Rejection
Specimens stored at incorrect temperature; Non-viable specimens; Specimens in inappropriate anticoagulant; Too few cells; Hemolysis; Specimen clotted
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 48 hours at 4°C |